Our study indicates that levels of proteins PERP, GNAS2, GNA13, ITB1, and RAB10 in EVs emitted by cultured breast cancer cells correlate with sensitivity of these cells to trastuzumab. The gene discussed is PERP; the disease is breast cancer.